Biomedicines logo

Biomedicines

Recent Finacing

Equity

Recent Raise

Undisclosed


Generate:Biomedicines is a clinical-stage biotherapeutics company that uses a machine-learning-powered generative biology platform to develop new drugs across oncology, immunology, and infectious disease.

Total Funding

$700M

Headquarters

Somerville, USA

Founded

2020

Focus Areas

Biotherapeutics
Machine Learning in Drug Development
Generative Biology

Investors